| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |